Talk:Alnylam Pharmaceuticals
Appearance
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||
|
Edits of this day
[edit]Fixed location of infobox. Removed close association tag, because the article has not been updated to any significant extent, in that manner, in a couple of years.
However, the article is in awful shape (dated, incomplete, and still somewhat news-release-like), so other text was added, and other tags place. Please discuss here before removing, unless they clearly are in error with regard to the specific matter raised.
Moved the following primary sources to Talk,[1][2][3] so that secondary sources can be added, and when added can be in proper format, not inappropriate (as in 3, which requires WP:OR) or primary sources (as in 1 and 2), and sloppy like these.
- ^ "Potent and specific genetic interference by double stranded RNA in Caenorhabditis elegans". FIRE, A.; XU, S.; MONTGOMERY, M.K.; KOSTAS, S.A.; DRIVER, S.E. and MELLO, C.C. , Nature, 1998, vol. 391, no. 6669, p. 806-811.
- ^ "Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells" ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K. & TUSCHL, T. (2001). Nature 2001, vol 411, pp: 494-8.
- ^ "ALAS1 aminolevulinate, delta-, synthase 1 [ Homo sapiens (human) ]". National Center for Biotechnology Information. Retrieved 4 September 2013.
Le Prof 02:28, 11 December 2015 (UTC)
Categories:
- Start-Class United States articles
- Low-importance United States articles
- Start-Class United States articles of Low-importance
- Start-Class Massachusetts articles
- Low-importance Massachusetts articles
- WikiProject Massachusetts articles
- Start-Class Boston articles
- Low-importance Boston articles
- WikiProject Boston articles
- WikiProject United States articles
- Start-Class company articles
- Low-importance company articles
- WikiProject Companies articles